IFX-3

N/A

Report date: 2024/01/10 15:13:40

Base Information

Drug NameIFX-3
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInflammation mediator inhibitorsComplement C5a inhibitors
TargetsComplement C5a
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInflarx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInflarx
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A